Business Context and Reporting Period
This Form 8-K Current Report was filed by Disc Medicine, Inc. (Nasdaq: IRON) on February 26, 2024. The report discloses a material corporate event under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Exhibits).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel appointment and does not contain financial performance data.
Material Changes
- Executive Appointment: The Company announced the appointment of Pamela Stephenson as Chief Commercial Officer.
- Inducement Grant: An inducement grant was issued to Ms. Stephenson, which is material to her acceptance of employment and complies with Nasdaq Listing Rule 5635(c)(4).
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary regarding future performance. The document explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act and the Company undertakes no obligation to update or amend the attached press release.
Investor Verification Checklist
- Verify the specific terms of the inducement grant issued to Pamela Stephenson in the attached press release (Exhibit 99.1).
- Confirm the effective date of Ms. Stephenson's appointment as Chief Commercial Officer.
- Review the Company's most recent 10-K or 10-Q filings for current financial metrics, as this 8-K does not contain them.